A Birth Control Vaccine is on the Horizon for Family Planning

References

• Talwar G P, Om Singh Pal R. Vaccines for control of fertility. Perspectives in primate reproductive biology, N R Moudgal, K Yoshinaga, A J Rao, P R Adiga. Wiley Eastern, New Delhi 1991; 269–76
   Google Scholar
• Ladd A, Prabhu G, Tsong Y Y, Probst T, Chung W, Thau R. Active immunization against gonadotropin releasing hormone combined with antigen supplementation is a promising antifertility vaccine for males. Am J Reprod Immunol Microbiol 1988; 17: 121–7
   PubMed Web of Science ®Google Scholar
• Jayashankar R, Chaudhuri M K, Om Singh Alam A, Talwar G P. Semisynthetic vaccine causing atrophy of the prostate. Prostate 1989; 14: 3–11
   PubMed Web of Science ®Google Scholar
• Moudgal N R, Murthy G S, Ravindranath N, Rao A J, Prasad M R N. Development of a contraceptive vaccine for use by the human male: results of a feasibility study carried out in adult male bonnet monkeys (Macaca radiata). Contraception research for today and the nineties, G P Talwar. Springer-Verlag, New York 1988; 253–60
   Google Scholar
• Primakoff P, Lathrop W, Woolman L, Cowan A, Myies D. Fully effective contraception in male and female guinea pigs immunized with sperm protein PH-20. Nature 1988; 335: 543–6
   PubMed Web of Science ®Google Scholar
• Shaha C, Suri A, Talwar G P. Induction of infertility in female rats after active immunization with 24KD antigens from rat testes. Int J Androl 1990; 13: 17–25
   PubMedGoogle Scholar
• Herr J C, Flicklngen C J, Homyk M, Klotz K, John E. Biochemical and morphological characterization of the intra-acrosomal antigen SP-10 from human sperm. Biol Rep 1990; 42: 181–93
   PubMed Web of Science ®Google Scholar
• Goldberg E. Lactate dehydrogenase C4 as an immunocontraceptive model. Gameté interaction, prospects for immunocontraception, N Alexander, D Griffin, J Spieler, G MH Waites. Wiley Liss Inc, New York 1991; 63–73
   Google Scholar
• Naz R K. Involvement of fertilization antigen (FA-1) in involuntary immuno-infertility in humans. J Clin Invest 1987; 80: 1375–83
   PubMed Web of Science ®Google Scholar
• Sacco A G. Zona pellucida: current status as a candidate antigen for contraceptive vaccine development. Am J Reprod Immunol Microbiol 1987; 15: 122–30
   PubMedGoogle Scholar
• Bamezal A K, Suman Das C, Talwar G P. Effect of immunization against zona pellucida (PZP) on steroid hormone profiles and fertility in primates. J Reprod Immunol 1986; 85, Suppl.
   PubMedGoogle Scholar
• Skinner S M, Mills T, Kirchick H J, Dunbar B S. Immunization with zona pellucida proteins results in abnormal ovarian follicular differentiation and inhibition of gonadotropin induced steroid secretion. Endocrinology 1984; 115: 2418–32
   PubMed Web of Science ®Google Scholar
• Miller S E, Chamow S M, Baur A W, Oliver C, Robey F, Dean J. Vaccination with a synthetic zona pellucida peptide produces long-term contraception in female mice. Science 1989; 246: 935–8
   PubMedGoogle Scholar
• Csapo Al, Pulkklnen M O, Ruttner B, Sauvage J P, Wiest W G. The significance of the human corpus luteam in pregnancy maintenance 1. Preliminary studies. Am J Obstet Gynecol 1972; 112: 1061–7
   PubMed Web of Science ®Google Scholar
• Fishel S B, Edwards R G, Evans C J. Human chorionic gonadotropin secreted by preimplantation embryos cultured in vitro. Science 1984; 223: 816–8
   PubMed Web of Science ®Google Scholar
• Hearn J P, Gidley-Baird A A, Hodges J K, Summers P M, Wlbley G E. Embryonic signals during the preimplantation period in primates. J Reprod Fertil (Suppl.) 1988; 36: 49–58
   PubMedGoogle Scholar
• Talwar G P, Sharma N C, Dubey S K, et al. Isoimmunization against human chorionic gonadotropin with conjugates of processed β-subunit of the hormone and tetanus toxoid. Proc Natl Acad Sci USA 1976; 73: 218–22
   PubMed Web of Science ®Google Scholar
• Prasad C R, Srimal R C, Dhawan B N. Acute toxicity and pharmacology of β-human chorionic gonadotropin conjugated tetanus toxoid (Pr-β-HCG-TT). Contraception 1976; 13: 189–200
   PubMedGoogle Scholar
• Sharma N C, Goal B K, Bajaj J S, Talwar G P. Metabolic, endocrine and organ functions in monkeys immunized with Pr-β-HCG-TT vaccine. Contraception 1976; 13: 201–11
   PubMedGoogle Scholar
• Nath I, Gupta P D, Bhuyan U N, Talwar G P. Autopsy report on rhesus monkeys immunized with Pr-β-hCG-TT vaccine. Contraception 1976; 13: 213–24
   PubMedGoogle Scholar
• Gupta P D, Nath I, Talwar G P. Immunofluorescence and electron microscopic studies on kidney, choroid plexus and pituitary in rhesus monkeys immunized with the anti-hCG vaccine Pr-β-hCG-TT. Contraception 1978; 18: 91–104
   PubMedGoogle Scholar
• Talwar G P, Dubey S K, Salahuddin M, Das C, Hingorani V, Kumar S. Antibody response to Pr-β-HCG-TT vaccine in human subjects. Contraception 1976; 13: 237–43
   PubMedGoogle Scholar
• Kumar S, Sharma N C, Bajaj J S, Talwar G P, Hingorani V. Clinical profile toxicology studies on four women immunized with Pr-β-hCG-TT. Contraception 1976; 13: 252–8
   Google Scholar
• Hingorani V, Kumar S. Anti-hCG immunization — phase I clinical trials. Recent advances in reproduction and regulation of fertility, G P Talwar. Elsevier, Amsterdam 1979; 467–72
   Google Scholar
• Shahani S M, Kulkarnl P P, Patel K L, Salahuddin M, Das C, Talwar G P. Clinical and immunological responses with Pr-β-hCG-TT vaccine. Contraception 1982; 25: 421–34
   PubMed Web of Science ®Google Scholar
• Ramakrishnan S, Dubey S K, Das C, et al. Influence of HCG and tetanus toxoid injections on the antibody titres in a subject immunized with Pr-β-HCG-TT. Contraception 1976; 13: 245–51
   PubMedGoogle Scholar
• Nash H, Talwar G P, Segal S, et al. Observations on the antigenicity and clinical effects of a candidate anti-pregnancy vaccine: β-subunit of human chorionic gonadotropin linked to tetanus toxoid. Fertil Steril 1980; 34: 328–35
   PubMed Web of Science ®Google Scholar
• Talwar G P. Contraceptive vaccines. Advances in fertility research, D R Mishell, Jr. Raven Press, New York 1982; 171–86
   Google Scholar
• Om Singh Shastrl N, Narang B S, Talwar G P. Immuno-prophylaxis: Search for an adjuvant acceptable in humans. Cellular and humoral mechanism in immune response. Department of Atomic Energy, New Delhi 1982; 114–8
   Google Scholar
• Talwar G P, Om Singh Rao LV. An improved immunogen for anti-human chorionic gonadotropin vaccine eliciting antibodies reactive with a conformation native to the hormone without crossreaction with human follicle stimulating hormone and human thyroid stimulating hormone. J Reprod Immunol 1988; 14: 203–12
   PubMed Web of Science ®Google Scholar
• Gaur A, Arunan K, Om Singh Talwar GP. Bypass by an alternate carrier of acquired unresponsiveness to hCG upon repeated immunization with tetanus conjugated vaccine. Int Immunol 1990; 2: 151–5
   PubMedGoogle Scholar
• Thau R B, Sundaram K, Thornton Y S. Effects of immunization with the β-subunit of ovine luteinizing hormone on corpus luteum function in the rhesus monkeys. Fertil Steril 1979; 31: 200–4
   PubMedGoogle Scholar
• Thau R B. Active immunization of rhesus monkeys against the β-subunit of ovine luteinizing hormone: Evaluation of safety and effectiveness of antigonadotropin vaccine. Contraception research for today and the nineties, G P Talwar. Springer-Verlag, New York 1988; 217–30
   Google Scholar
• Thau R B, Wilson C B, Sundaram K, et al. Long-term immunization against the β-subunit of ovine luteinizing hormone (oLHβ) has no adverse effect on pituitary functions in rhesus monkeys. Am J Reprod Immunol Microbiol 1987; 15: 92–8
   PubMed Web of Science ®Google Scholar
• Om Singh Rao LV, Gaur A, Sharma N C, Alam A, Talwar G P. Antibody response and characteristics of antibodies in women immunized with three contraceptive vaccines inducing antibodies against human chorionic gonadotropin. Fertil Steril 1989; 52: 739–44
   PubMedGoogle Scholar
• Kharat I, Nair N S, Dhall K, et al. Analysis of menstrual records of women immunized with anti-hCG vaccines inducing antibodies partially cross-reactive with hLH. Contraception 1990; 41: 293–9
   PubMed Web of Science ®Google Scholar
• Talwar G P, Hingorani V, Kumar S, et al. Phase I clinical trials with three formulations of anti-human chorionic gonadotropin vaccine. Contraception 1990; 41: 301–16
   PubMed Web of Science ®Google Scholar
• Pal R, Om Singh Rao LV, Talwar G P. Bioneutralization capacity of the antibodies generated in women by the beta subunit of human chorionic gonadotropin (bThCG) and βhCG associated with alpha subunit of ovine luteinizing hormone linked to carriers. Am J Reprod Immunol 1990; 22: 124–6
   PubMedGoogle Scholar
• Upadhyay S N, Kaushic C, Talwar G P. Antifertility effects of neem (Azadirachta indica) oil by a single intrauterine administration: a novel method for contraception. Proc R Soc Lond B 1990; 242: 175–9
   PubMed Web of Science ®Google Scholar
• Singh M, Singh A, Talwar G P. Controlled delivery of diphtheria toxoid using biodegradable poly (D, L-lactide) microcapsules. Pharm Res 1991; 8: 958–61
   PubMed Web of Science ®Google Scholar
• Lall L, Srínivasan J, Rao L V, Talwar G P, Chakrabarti S. Recombinant vaccinia virus expresses immunoreactive alpha subunit of ovine luteinizing hormone which associates with β-hCG to generate bioactive dimer. Ind J Biochem Biophys 1988; 25: 510–4
   PubMedGoogle Scholar
• Chakrabarti S, Srinivasan J, Lall L, Rao L V, Talwar G P. Expression of biologically active human chorionic gonadotropin and its subunits by recombinant vaccinia virus. Gene 1989; 77: 87–93
   PubMedGoogle Scholar
• Srinivasan J, Om Singh Pal R, Lall L, Chakrabarti S, Talwar G P. A recombinant anti-fertility vaccine. Local immunity in reproductive tract tissues. WHO Symposium. 1991, in press
   Google Scholar